Medicine
Droxidopa 100 mg capsule
Droxidopa 100 mg capsule is a generic prescription medicine for oral use, made by 12 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Droxidopa capsules should be stored at 20°C to 25°C (68°F to 77°F), excursions…
Key facts
- Active ingredient (INN)
- Droxidopa
- Brand
- Sold under the generic name
- Strength
- 100 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 90 capsules, 500 capsules, 1000 capsules and 13 more
- Manufacturers
- Ascend LaboratoriesIndiaNovadoz PharmaceuticalsIndiaZydus LifesciencesIndiaAurobindo PharmaIndiaCamber PharmaceuticalsIndiaScieGen PharmaceuticalsBionpharmaCivicaScriptGolden State Medical SupplyMajor Pharmaceuticals12 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Droxidopa capsules should be stored at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C01CA27 Droxidopa
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 18 February 2021
- Identifiers
- RxCUI 1490026, 1490034, 1490038DailyMed set ID aa3ce55a-1ea9-4b50-b682-6f25398bcc29, 381ffe44-d5d8-4380-a3cd-6d6a5e9ef55d, 049f997b-1649-467e-bbb9-bdb991b0bc6e +10NDC 70710-1389, 72205-072, 70436-140 +10Application ANDA211818, ANDA211741, ANDA215265 +6
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 90 capsule in 1 bottle | 70710-1389-9 | Zydus LifesciencesIndia | 19 February 2021 |
| 90 capsule in 1 bottle | 70771-1609-9 | Zydus LifesciencesIndia | 19 February 2021 |
| 500 capsule in 1 bottle | 67877-704-05 | Ascend LaboratoriesIndia | 19 February 2021 |
| 90 capsule in 1 bottle | 67877-704-90 | Ascend LaboratoriesIndia | 19 February 2021 |
| 90 capsule in 1 bottle | 59651-375-90 | Aurobindo PharmaIndia | 18 February 2021 |
| 90 capsule in 1 bottle | 31722-014-90 | Camber PharmaceuticalsIndia | 9 August 2021 |
| 500 capsule in 1 bottle | 72205-072-05 | Novadoz PharmaceuticalsIndia | 19 February 2021 |
| 90 capsule in 1 bottle | 72205-072-90 | Novadoz PharmaceuticalsIndia | 19 February 2021 |
| 90 capsule in 1 bottle, plastic | 69452-256-19 | Bionpharma | 1 October 2021 |
| 90 capsule in 1 bottle | 82249-551-90 | CivicaScript | 3 March 2025 |
| 1000 capsule in 1 bottle | 50228-429-10 | ScieGen Pharmaceuticals | 18 February 2021 |
| 30 capsule in 1 bottle | 50228-429-30 | ScieGen Pharmaceuticals | 18 February 2021 |
| 90 capsule in 1 bottle | 50228-429-90 | ScieGen Pharmaceuticals | 18 February 2021 |
| 90 capsule in 1 bottle | 70436-140-06 | Slate Run Pharmaceuticals | 10 November 2021 |
| 90 capsule in 1 bottle | 51407-765-90 | Golden State Medical Supply | 18 April 2023 |
| 90 capsule in 1 bottle | 0904-7392-89 | Major Pharmaceuticals | 28 December 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 18 February 2014 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Droxidopa 100 mg capsule.
Other strengths and forms of Droxidopa
Clinical summary
Droxidopa is a prescription medicine indicated for the treatment of orthostatic dizziness, among other approved uses. It is available as capsules for oral use. MedsAcross supplies Droxidopa for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DroxidopaFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Northera prescribing information (Lundbeck Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Droxidopa 100 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.